Home » Business, Europe, Health & Medicine, Pharmaceuticals & Biotech » Autoimmune Disease Diagnostics Market size worth $15bn by 2023: Global Market Insights Inc.
“Introduction of innovative technologically advanced products such as Celiac Panel Test by SQI Diagnostics that enables faster IgG & IgA antibodies detection, and customized time saving, multifunctional kits such as ImmunoSEQtime should further contribute”
Autoimmune Disease Diagnostics Market Size By Product [Systemic (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE)), Localized], Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, U.K, Japan, China, Brazil) Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023

Autoimmune disease diagnostics market is revolutionizing the healthcare industry due to alarming rates of autoimmune diseases globally. Autoimmune diseases are self-inflicted diseases caused due to the abnormal immune response to a body part. As per the NIH Autoimmune Disease Coordinating Committee (ADCC), 14-22 million people in the U.S. are affected by some sort of autoimmune diseases. Another study depicts 7 million people in the Europe to be suffering from autoimmune ailments. Moreover, NIH (National Institutes of Health) mentions autoimmune diseases to be one of the top 10 causes of female demise in the U.S.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/618

The issue has been a matter of serious concern worldwide and is being addressed by measurements taken at individual and government levels. According to a report on Autoimmune Disease Diagnostics Market by Global Market Insights Inc., “the global autoimmune disease diagnostics market worth USD 12.8 billion in 2015, is anticipated to grow at a moderate CAGR of 2.5%, hitting USD 15 billion in 2023.” Growing prevalence of these diseases, rising awareness among patients, and government initiatives towards reducing the frequency of such ailments will be the major factors driving the market growth over the next eight years, as per the report.

The frequent occurrence of these diseases has resulted in a huge healthcare expenditure. The treatment of autoimmune ailments is way costlier and is a serious concern to the overall healthcare system. For instance, annual medical expenditure for the treatment of multiple sclerosis (a type of autoimmune disease) comes to approximately USD 2.5 billion, a cost higher than that incurred during diabetes treatment.

Autoimmune Disease Diagnostics Market Size, By Product, 2012 – 2023 (USD Million)

Autoimmune Disease Diagnostics Market Size, By Product, 2012 - 2023 (USD Million)

Government measures addressing this global issue is favorably impacting the growth of new diagnostic methods to detect and cure such ailments, in turn favoring the global autoimmune disease diagnostics market. The month of March has been designated as the “National Autoimmune Disease Awareness Month.” Another remarkable development in the field of autoimmune disease diagnostics is the formation of Autoimmunity Centers of Excellence (ACE) by the collaboration of NIH, non-profit organizations, and pharmaceutical companies which performs various researches for the development of diagnostic tools.

The U.S will be leading the North America autoimmune disease diagnostics market due to the high occurrence of related ailments accompanied by rising patient awareness in this region. The market is estimated to reach USD 3.5 billion by 2023. North America will be dominating the global market over the coming years.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/618

Europe market is set to secure the second position globally driven by the government support in these regions. Germany and UK will drive the regional growth. The Asia Pacific, on account of its large patient pool, is pegged to grow at a CAGR of 5.3% over the period of 2016-2023.

On the product front, the localized autoimmune disease diagnostics will dominate the systematic diagnostics segment over the coming period. The localized autoimmune disease diagnostics market is likely to surpass USD 10 billion by 2023.

The industry is fragmented and is being influenced by the ongoing trends of diagnostics industry such as developments in genetic testing, rise in the personalized medicine industry, focus towards prevention rather than treatment, etc. The players are making huge investments in the R&D and their respective product innovations to meet the growing technological demands. Major industry participants are Siemens Healthineers, Roche Diagnostics, Euroimmun, Abbott Laboratories, Beckman Coulter Inc., Quest Diagnostics, SQI Diagnostics Inc, and INOVA Diagnostics, Inc.

Browse key industry insights spread across 82 pages with 30 market data tables & 28 figures & charts from the report, “Autoimmune Disease Diagnostics Market Size By Product [Systemic (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE)), Localized], Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, U.K, Japan, China, Brazil) Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/autoimmune-disease-diagnostics-market

 

Global Market Insights has segmented the autoimmune disease diagnostics industry on the basis of product, and region:

Global Autoimmune Disease Diagnostics Product Market Analysis (Revenue, USD Million; 2012 – 2023)

  • Systemic
    • Rheumatoid Arthritis
    • Ankylosing Spondylitis
    • Systemic lupus Erythematosus (SLE)
    • Others
  • Localized

Autoimmune Disease Diagnostics Market Regional Analysis (Revenue, USD Million, 2012 – 2023)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia-Pacific
    • Japan
    • China
  • Latin America
    • Brazil
  • MEA

 

Browse Related Reports:

  • Antidiabetics Market Size By Product (Insulin [Rapid Acting, Long Acting, Premixed, Short Acting, Intermediate Acting], Alpha-Glucosidase Inhibitors, Biguanides, Sulphonylureas, GLP-1 Agonist, Meglitinides, DPP-4 Inhibitors, SGLT-2, Thiazolodinediones), By Application (Type I Diabetes, Type II & Other), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023

       https://www.gminsights.com/industry-analysis/antidiabetics-market

  • Precision Medicine Market Size By Technology (Big Data Analytics, Gene Sequencing, Drug Discovery, Bioinformatics, Companion Diagnostics), By Application (Oncology, CNS, Immunology, Respiratory), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Scandinavia, Italy, Japan, China, India, Singapore, Mexico, Brazil, South Africa, UAE, Qatar, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023

       https://www.gminsights.com/industry-analysis/precision-medicine-market

 

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Media Contact
Company Name: Global Market Insights Inc.
Contact Person: Jack Davis
Email: sales@gminsights.com
Phone: 1-302-846-7766
Address:29L Atlantic Avenu, Suite L 105
City: Ocean View
State: Delaware
Country: United States
Website: https://gminsights.wordpress.com/2016/10/26/autoimmune-disease-diagnostics-market/

Comments are closed.